Track topics on Twitter Track topics that are important to you
Elektrovej Building 375
Phone: 45 4526 5050
Fax: 45 4526 5060
Symphogen Further Strengthens its Immuno-Oncology Pipeline by Advancing into Two Additional Clinical Trials Seventh Program to enter Clinical Development at Symphogen Symphogen’s antibody platfo...
SummarySymphogen A/S Symphogen is a biopharmaceutical company that specializes in the field of recombinant antibody mixtures for therapeutic use in cancer. The company focuses on developing superior m...
This edition presents the views and insights from three world leading key opinion leaders KOLs from North America and Europe on a variety of recent events in the colorectal cancer CRC market, includin...
Symphogen is developing superior antibody therapeutics (monoclonal, monoclonal mixtures and polyclonal) to help people with serious diseases and significant unmet medical needs. W...
Symphogen A/S, the biotech company pioneering recombinant human polyclonal antibodies for the treatment and prevention of human disease, today announced the initial closing of a USD 25 million Series ...
We have published hundreds of Symphogen A/S news stories on BioPortfolio along with dozens of Symphogen A/S Clinical Trials and PubMed Articles about Symphogen A/S for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Symphogen A/S Companies in our database. You can also find out about relevant Symphogen A/S Drugs and Medications on this site too.
Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...